No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

The US Department of Health and Human Services awarded Moderna $590 million to continue developing a vaccine to protect against bird flu.

The number of bird flu cases in Central Massachusetts is relatively low, compared to a swath of the state that runs from ...

The Centers for Disease Control and Prevention abruptly ordered its staff to cease all collaboration with the World Health ...

Moderna is working with the Department of Health and Human Services to develop a vaccine to combat bird flu. Human to human ...

As more cases of bird flu emerge across the country, public health leaders in New York City are watching warily -- and making ...

Moderna's stock roared higher on the back of ... The company is currently working on vaccines for RSV and the seasonal flu, as well as some rare diseases. However, right now, it is still seeing ...

The trial looked at the efficacy of mRNA-1083 in one group of adults 65 years and older who received Moderna’s jab or Sanofi’s high-dose flu vaccine Fluzone HD, co-administered with Moderna ...

Moderna works on mRNA vaccines ... The company is currently working on vaccines for RSV and the seasonal flu, as well as some rare diseases. However, right now, it is still seeing stagnating ...

In return for the funding, funds managed by Blackstone will be in line to receive milestones and royalties on any flu vaccine products that emerge from the programme. Moderna will see a reduction ...

The new bird flu vaccine deal marks the second deal the company bagged after the $176-million H5N1 avian influenza virus awarded earlier. Moderna was previously awarded funds to develop a COVID-19 ...